Jefferies starts Verastem at Buy


Verastem (VSTM +1.7%) is initiated with a Buy rating at Jefferies. Price target is $21, representing a 42% upside from Friday's close.

Analyst Biren Amin says VS-6063 "has favorable odds of showing a PFS benefit [in mesothelioma trials], supporting potential accelerated approval in H2 2016."

 For more on VS-6063, see previous coverage.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs